Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice.
about
HBV pathogenesis in animal models: recent advances on the role of plateletsNKT cell subsets as key participants in liver physiology and pathologyHepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genesHepatitis B: future curative strategiesEfficacy of cationic lipid–DNA complexes (CLDC) on hepatitis B virus in transgenic miceElevation of interleukin-18 in chronic hepatitis C: implications for hepatitis C virus pathogenesisAsian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.Immune effectors required for hepatitis B virus clearanceEffect of dipterinyl calcium pentahydrate on hepatitis B virus replication in transgenic mice.Novel approaches towards conquering hepatitis B virus infection.Toll-like receptor signaling inhibits hepatitis B virus replication in vivo.Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liver.Interleukin 18 gene promoter polymorphisms and susceptibility to chronic hepatitis B infection: a review study.Transforming growth factor-β1 suppresses hepatitis B virus replication by the reduction of hepatocyte nuclear factor-4α expression.Establishment and primary application of a mouse model with hepatitis B virus replication.Blockade of neutrophil elastase attenuates severe liver injury in hepatitis B transgenic miceDownregulation of interleukin-18-mediated cell signaling and interferon gamma expression by the hepatitis B virus e antigen.TGF-β and iron differently alter HBV replication in human hepatocytes through TGF-β/BMP signaling and cellular microRNA expression.Searching for interferon-induced genes that inhibit hepatitis B virus replication in transgenic mouse hepatocytes.Inhibition of hepatitis B virus replication by the host zinc finger antiviral protein.Association of polymorphisms in interleukin-18 and interleukin-28B genes with outcomes of hepatitis B virus infections: a meta-analysis.Association of polymorphisms of interleukin-18 gene promoter region with chronic hepatitis B in Chinese Han populationBreaking B and T cell tolerance using cationic lipid--DNA complexes (CLDC) as a vaccine adjuvant with hepatitis B virus (HBV) surface antigen in transgenic mice expressing HBVHigh plasma interleukin-18 levels mark the acute phase of hepatitis C virus infectionAIC649 Induces a Bi-Phasic Treatment Response in the Woodchuck Model of Chronic Hepatitis B.Tumor necrosis factor activates a conserved innate antiviral response to hepatitis B virus that destabilizes nucleocapsids and reduces nuclear viral DNA.Activation and function of hepatic NK cells in hepatitis B infection: an underinvestigated innate immune response.Anti-hepatitis B virus (HBV) response of imiquimod based toll like receptor 7 ligand in hbv-positive human hepatocelluar carcinoma cell line.Establishment of mice model with human viral hepatitis B.Roles of heat-shock protein 70 in protecting against intestinal mucosal damageImmunopathogenesis of hepatitis B virus infection.Human Cytokine Genetic Variants Associated With HBsAg Reverse Seroconversion in Rituximab-Treated Non-Hodgkin Lymphoma Patients.Hepatitis B virus genome replication triggers toll-like receptor 3-dependent interferon responses in the absence of hepatitis B surface antigenPrimary occult hepadnavirus infection induces virus-specific T-cell and aberrant cytokine responses in the absence of antiviral antibody reactivity in the Woodchuck model of hepatitis B virus infectionHBV replication is significantly reduced by IL-6.Association of IL-18 promoter polymorphism with liver disease severity in HCV-infected patients.Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases.Role of viral and host factors in interferon based therapy of hepatitis C virus infectionLiver immune-pathogenesis and therapy of human liver tropic virus infection in humanized mouse models.The role of innate immunity in HBV infection.
P2860
Q24672103-AFA361B9-6434-4F50-B234-9650D661F86FQ26766141-E8C97BA3-4BFB-4C9E-B88C-442E76DDC31AQ26772317-F31A380A-2635-44AB-8EC0-945F404D6A32Q27011623-CEEE5D1B-6829-42B5-B48E-ED35D84E3632Q27486380-E8759C3A-1447-42ED-9F48-6EB6B586F1D8Q27489815-0D32CB28-3B2F-4490-9F99-70413CBF5963Q30391932-72F93F79-7B09-4A40-BB13-42C47CB74130Q33640225-2ECC0A1D-1BFE-4EDC-AB79-B07C79F03BABQ33784869-1CDF268A-E169-4C60-B359-7BED3BBE95E4Q33787687-E1DDCD78-F329-4203-9F8B-7E1C7730F595Q33788761-BBC32A67-39A2-4FEA-B3C1-AE2AB440978BQ33812840-F3CE79D1-A34D-47C6-8F5C-7DAA17ED02D2Q33839843-A381D54F-B6AC-4B28-B8F0-DA08D6B926C7Q34140521-C09B6066-3643-4BA9-A3B3-6AD4E91B9542Q34225729-E62462A3-1543-44F8-BC5B-DEB69E1BC6E6Q34228477-4F392A4A-BE73-450E-ACDF-2838207ED6F6Q34262225-526BBD90-AA35-42FC-9155-E1F6B662F1C5Q34314364-38EF92F4-18EB-45CF-AA64-2D80DC3E7C78Q34465900-FD4AEFF6-44C9-4069-8AAE-F4024848352DQ34819738-70EE2BD3-5CBF-470D-B385-AC34E893812EQ34985468-F86431B5-9686-4044-9F41-788D2EF713D4Q35011343-CCAEAD12-BA9E-46FE-95C8-D3A50E769B50Q35052956-93D60370-D23B-4255-BCA7-1B9705A08E3AQ35463737-5938DCFE-443B-4FA8-BCD4-62BE27156EC7Q35866293-AF90B97D-0CEE-4CCD-A282-7B91D7068F25Q35914476-568C1240-7A53-4974-A161-6AD56DC2284BQ36011955-D3F70AAE-A00D-4675-B0C6-8CD50FA5EA2DQ36249804-F6DCA254-BF34-4208-B71F-BBEB080CED94Q36502579-27EA1199-FA7D-4898-B13F-0F9956819991Q36664121-78C3BFED-949C-4C56-9AB6-D211CDFEAA9DQ36666336-78EEE748-F823-46FC-80B0-52B37A2E3AF6Q36822761-E9DC7DE1-479C-4490-BFE8-109B18457FA6Q36845647-F2E85EA6-6A5B-43FF-801E-62B0457835A9Q37145259-5194E80C-EDC9-4C37-B2D2-37E1F96ECABAQ37204748-4E8EA0CF-5899-4A2C-B3C9-721A81214D98Q37277880-E3A2BAF9-AE3E-4CE9-801C-2F795C418493Q37326768-B36563ED-563D-44A4-80F7-B6DA3CE5C60FQ37362240-BB966B16-84ED-4833-8E47-9079C0A4778AQ37677390-B22F8692-650B-4670-A111-C1F8639FB074Q38027754-1DA68299-DD9F-4DF1-97A9-503641BC89BB
P2860
Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice.
@ast
Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice.
@en
Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice.
@nl
type
label
Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice.
@ast
Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice.
@en
Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice.
@nl
prefLabel
Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice.
@ast
Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice.
@en
Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice.
@nl
P2093
P2860
P1433
P1476
Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice
@en
P2093
Kazuhiro Kakimi
Luca G Guidotti
Stefan Wieland
P2860
P304
10702-10707
P356
10.1128/JVI.76.21.10702-10707.2002
P407
P577
2002-11-01T00:00:00Z